CALCITRIOL INJECTION SOLUTION

Страна: Канада

Език: английски

Източник: Health Canada

Купи го сега

Активна съставка:

CALCITRIOL

Предлага се от:

FRESENIUS KABI CANADA LTD

АТС код:

A11CC04

INN (Международно Name):

CALCITRIOL

дозиране:

1MCG

Лекарствена форма:

SOLUTION

Композиция:

CALCITRIOL 1MCG

Начин на приложение:

INTRAVENOUS

Броя в опаковка:

1ML

Вид предписание :

Prescription

Терапевтична област:

VITAMIN D

Каталог на резюме:

Active ingredient group (AIG) number: 0113628002; AHFS:

Статус Оторизация:

CANCELLED POST MARKET

Дата Оторизация:

2023-03-10

Данни за продукта

                                PRODUCT MONOGRAPH
PR
CALCITRIOL INJECTION
1 MCG/ML AND 2 MCG/ML
Vitamin D
3
metabolite
FRESENIUS KABI CANADA LTD.
165 Galaxy Blvd, Suite 100
Date of Revision:
Toronto, ON, M9W 0C8
November 16, 2017
Submission Control No.: 199558
Calcitriol Injection – Product Monograph
_ _
Page 2 of 23
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.............................................................. 3
SUMMARY PRODUCT INFORMATION
.....................................................................................
3
INDICATIONS AND CLINICAL USE
...........................................................................................
3
CONTRAINDICATIONS
................................................................................................................
3
WARNINGS AND PRECAUTIONS
...............................................................................................
4
ADVERSE REACTIONS
.................................................................................................................
6
DRUG INTERACTIONS
.................................................................................................................
8
DOSAGE AND ADMINISTRATION
.............................................................................................
9
OVERDOSAGE
.............................................................................................................................
10
ACTION AND CLINICAL PHARMACOLOGY
.........................................................................
10
STORAGE AND STABILITY
.......................................................................................................
12
SPECIAL HANDLING INSTRUCTIONS
....................................................................................
12
DOSAGE FORMS, COMPOSITION AND
PACKAGING...........................................................
12
PART II: SCIENTIFIC INFORMATION
...................................................................................
13
PHARMACEUTICAL INFORMATION
......
                                
                                Прочетете целия документ
                                
                            

Документи на други езици

Данни за продукта Данни за продукта френски 16-11-2017

Сигнали за търсене, свързани с този продукт

Преглед на историята на документите